Ben Greene

Ben Greene is an accomplished professional with extensive experience in the biotechnology and pharmaceutical industry. As a Principal Scientist 3 at Charles River Laboratories since May 2022, Ben leads pharmacokinetic discovery studies. Prior experience includes significant roles at Genzyme and Sanofi Genzyme, where Ben contributed as a Senior Scientist and played a key role in rare disease project leadership and pharmacokinetics. Ben also served as a consultant at Guidepoint, providing insights on pre-clinical development, and worked at Roche Pharmaceuticals as a pharmacology expert in small molecule research. Ben holds a Bachelor of Science in Biology from the University of California, Davis.